Chromosome enzyme activation factor eye-care ointment and preparation method

Abstract

The invention discloses chromosome enzyme activation factor eye-care ointment. The chromosome enzyme activation factor eye-care ointment comprises the raw materials in parts by weight: 10-30 parts ofwater, 1-3 parts of compound chromosome enzyme activation factor, 5-20 parts of herba menthae, 0.5-1 part of xanthan gum, 10-20 parts of propylene glycol, 2-4 parts of dried longan pulp, 0.5-1.5 partsof natural borneol, 0.5-2 parts of radix notoginseng extract, 0.5-2 parts of lonicera japonica extract, 2-8 parts of fructus lycii, 6-10 parts of flos chrysanthemi and 12-20 parts of cassia seeds. Apreparation method for the eye-care ointment disclosed by the invention comprises the steps of mixing the compound chromosome enzyme activation factor, the herba menthae, the xanthan gum, the propylene glycol, the dried longan pulp, the natural borneol, the radix notoginseng extract, the lonicera japonica extract, the fructus lycii, the flos chrysanthemi and the cassia seeds, then, carrying out stirring until uniform concrete is formed, thereby obtaining the chromosome enzyme activation factor eye-care ointment. The eye-care ointment disclosed by the invention is high in safety and can be usedfor improving diseases i.e., ocular fundus lesions, presbyopia, muscae volitantes, vitreous opacity, macular degeneration, optic atrophy, pseudomyopia, amblyopia, hypermetropia, diminution of vision,ocular itching, dryness, ache, sore swelling, lachrymation, conjunctivitis and trachoma in an auxiliary manner. Furthermore, the compound chromosome enzyme activation factor eye-care ointment is alsoapplicable to the aged and children.

Description

[0001] The invention relates to the field of eye protection ointment, in particular to a chromosomal enzyme activating factor eye protection ointment and a preparation method thereof. Background technique [0002] According to the World Health Organization (WHO) statistics, there are 45 million blind people in the world, and 180 million people suffering from eye diseases, with various types of eye diseases. Age-related macular degeneration is an important cause of vision loss and blindness in the elderly, and senile eye diseases are the leading cause of blindness among middle-aged and elderly people over the age of 55 in Western countries. Age_related macular degeneration (AMD) causes blurred vision and blindness to 25 million to 30 million people worldwide. According to the survey and analysis, in addition to age and genetic factors, it is also related to the intake of antioxidants in food, sunlight stimulation, radiation, smoking, working environment, etc. With the rapid dev...

AI Technical Summary

Problems solved by technology

However, under the condition of sufficient nutrition supply, the cell division stops at about 50 generations, and it really enters the aging period. This discovery seems to tell people that there is an aging clock in the cell, which limits the number of cell divisions, and also limits the number of cell divisions. biological lifespan

Images